• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

CardioCell stem cells ‘improve well-being’ of heart failure patients

August 29, 2016

News


Aug 29, 2016

CardioCell stem cells ‘improve well-being’ of heart failure patients

fierce
After Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver–and over the weekend posted broadly positive data, but questions, and the need for more clinical data, remain.
The San Diego, CA-based biotech has published new, top-line data from the ESC Congress in Rome, Italy that used its allogeneic mesenchymal stem cells, delivered through an IV, to heart failure patients with non-ischemic cardiomyopathy. READ FULL ARTICLE

Media Coverage,  News

Reader Interactions

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2022 · Business Pro Theme on Genesis Framework · WordPress · Log in